Surveillance of therapy with aminoglycosides at a specialized hospital
Macías-Hernández, A.E.; León-Hernández, A.C.; Muñoz-Barrett, J.M.; Olivares-Durán, E.M.; Aguilar-Orozco, G.; Córdova-Rodríguez, C.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 45(4): 339-343
1993
ISSN/ISBN: 0034-8376 PMID: 8235135 Document Number: 7708
Aminoglycosides (AG) are excellent antibiotics against gram-negative bacilli infections, but their use implies potential ototoxicity and nephrotoxicity if an excessive dosage is prescribed. In this study we evaluated 105 episodes of AG treatment in 104 patients hospitalized in a specialty hospital in the city of Leon, Mexico. In each case a basal serum creatinine, weight and age were recorded. A single serum AG assay per episode of treatment was done. Either amikacin or gentamicin were one the AG prescribed. Prior to AG administration only 54 treatment episodes (51%) had a before treatment creatinine assay. The initial creatinine clearance showed normal values in 43% (23/54 episodes) and it was altered (below 80 mL/min) in 31 (57%) of the episodes. In the 31 cases with an altered renal function only 15 (48%) underwent dosage adjustment. In summary the AG were prescribed in excess in 54% (29/54) of the episodes. The serum AG levels within toxic range were observed in 11 episodes. These results suggest that in our hospital AG treatment is not adequately done and monitored.
Document emailed within 1 workday
